| Clinical update on cancer: molecular oncology of head and neck cancer Y Suh, I Amelio, T Guerrero Urbano, M Tavassoli Cell death & disease 5 (1), e1018-e1018, 2014 | 263 | 2014 |
| A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC). S Papa, A Adami, M Metoudi, D Achkova, M van Schalkwyk, ... Journal of Clinical Oncology 36 (15_suppl), 3046-3046, 2018 | 49 | 2018 |
| Should elective neck dissection be routinely performed in patients undergoing salvage total laryngectomy? TF Pezier, IJ Nixon, W Scotton, A Joshi, T Guerrero-Urbano, R Oakley, ... The Journal of Laryngology & Otology 128 (3), 279-283, 2014 | 42 | 2014 |
| Presenting pre-radiotherapy dental status of head and neck cancer patients in the novel radiation era V Patel, D Patel, T Browning, S Patel, M McGurk, I Sassoon, ... British dental journal 228 (6), 435-440, 2020 | 41 | 2020 |
| Outcomes of intensity‐modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma–a European singleinstitution analysis T Bird, F De Felice, A Michaelidou, S Thavaraj, JP Jeannon, A Lyons, ... Clinical Otolaryngology 42 (1), 115-122, 2017 | 41 | 2017 |
| The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication … M Hussein, S Aldridge, T Guerrero Urbano, A Nisbet The British journal of radiology 85 (1012), 423-432, 2012 | 39 | 2012 |
| 18F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma T Bird, S Barrington, S Thavaraj, JP Jeannon, A Lyons, R Oakley, R Simo, ... European journal of nuclear medicine and molecular imaging 43, 1239-1247, 2016 | 34 | 2016 |
| Clinical evaluation of tumour‐infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus‐associated oropharyngeal squamous cell carcinoma K Ruangritchankul, A Sandison, F Warburton, T Guerrero‐Urbano, ... Histopathology 75 (1), 146-150, 2019 | 31 | 2019 |
| Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT. V Paleri, J Patterson, N Rousseau, E Moloney, D Craig, D Tzelis, ... Health Technology Assessment (Winchester, England) 22 (16), 1-144, 2018 | 30 | 2018 |
| Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers DM Gujral, AB Miah, S Bodla, TM Richards, L Welsh, U Schick, CJ Powell, ... Oral oncology 50 (11), 1089-1097, 2014 | 29 | 2014 |
| Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy C Yip, C Thomas, A Michaelidou, D James, R Lynn, M Lei, ... The British Journal of Radiology 87 (1034), 20130532, 2014 | 28 | 2014 |
| Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary D Pencharz, J Dunn, S Connor, A Siddiqui, N Sriskandan, S Thavaraj, ... Clinical Radiology 74 (2), 165. e17-165. e23, 2019 | 27 | 2019 |
| Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy TF Pezier, IJ Nixon, A Joshi, L Pang, T Guerrero-Urbano, R Oakley, ... European Archives of Oto-Rhino-Laryngology 270, 1729-1735, 2013 | 27 | 2013 |
| What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer M Barbieri, HLA Weatherly, R Ara, H Basarir, M Sculpher, R Adams, ... Applied health economics and health policy 12, 497-510, 2014 | 26 | 2014 |
| Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma Y Suh, K Lawler, R Henley-Smith, L Pike, R Leek, S Barrington, EW Odell, ... British journal of cancer 116 (8), 1057-1064, 2017 | 23 | 2017 |
| Can 18F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer? F Ul-Hassan, R Simo, T Guerrero-Urbano, R Oakley, JP Jeannon, ... Clinical Nuclear Medicine 38 (4), 263-265, 2013 | 23 | 2013 |
| Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in … CC Parker, H Kynaston, AD Cook, NW Clarke, CN Catton, WR Cross, ... The Lancet 403 (10442), 2416-2425, 2024 | 20 | 2024 |
| Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma TF Pezier, IJ Nixon, A Joshi, T Guerrero-Urbano, R Oakley, JP Jeannon, ... European Archives of Oto-Rhino-Laryngology 271, 2503-2509, 2014 | 20 | 2014 |
| Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the … CC Parker, NW Clarke, AD Cook, H Kynaston, CN Catton, WR Cross, ... The Lancet 403 (10442), 2405-2415, 2024 | 19 | 2024 |
| Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study S Papa, A Adami, M Metoudi, R Beatson, MS George, D Achkova, ... Journal for Immunotherapy of Cancer 11 (6), 2023 | 18 | 2023 |
